[Evaluation of FreeStyle Libre in pediatric t1dm: improved glycemic control, reduction in diabetic ketoacidosis and severe hypoglycemia]. [PDF]
Probl Endokrinol (Mosk), 2022 Laptev DN +6 more
europepmc +1 more source
[Diabetic gastroenteropathy: modern methods of diagnosis and treatment]. [PDF]
Probl Endokrinol (Mosk), 2022 Kuznetsov KO +9 more
europepmc +1 more source
[Use of metformin in patients with type 2 diabetes and acute myocardial infarction: safety and impact on glycemic control]. [PDF]
Probl Endokrinol (Mosk), 2023 Korotina MA, Pochinka IG, Strongin LG.
europepmc +1 more source
[Synergistic effects of GABA and hypoglycemic drugs]. [PDF]
Probl Endokrinol (Mosk), 2023 Tyurenkov IN +2 more
europepmc +1 more source
[Dysglycemia in COVID-19 and Type 2 Diabetes Mellitus: Peculiarities of the Glycemic Profile in Hospitalized Patients and the Role of Steroid-Induced Disorders]. [PDF]
Probl Endokrinol (Mosk), 2022 Strongin LG +4 more
europepmc +1 more source
[Diabetes mellitus and the female reproductive system tumors]. [PDF]
Probl Endokrinol (Mosk), 2023 Sharafutdinova KI +7 more
europepmc +1 more source
[Effect of components of the renin-angiotensin system, rs2106809 polymorphism of the ACE2 gene, and therapy with RAS blockers on the severity of COVID-19]. [PDF]
Probl Endokrinol (Mosk), 2023 Zuraeva ZT +8 more
europepmc +1 more source
[The ketogenic diet: history, mechanism of action, indications and contraindications]. [PDF]
Probl Endokrinol (Mosk), 2021 Ivannikova EV +2 more
europepmc +1 more source
[Time-restricted eating as a novel strategy for treatment of obesity and it's comorbid conditions]. [PDF]
Probl Endokrinol (Mosk), 2022 Berkovskaya MA +3 more
europepmc +1 more source
[Semaglutide - effectiveness in weight loss and side effects when used according to studies by SUSTAIN, PIONEER, STEP]. [PDF]
Probl Endokrinol (Mosk), 2023 Shabutdinova OR +10 more
europepmc +1 more source